跳至主要内容
临床试验/IRCT2013081114330N1
IRCT2013081114330N1已完成未知

Evaluation of Curcumin anti-inflammatory effects on peripheral blood mononuclear cells in coronary artery disease and plaque stabilization serum level of CD40

Mashhad University of Medical Sciences,vice chancellor for research0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • The inclusion criteria: diagnosis of CAD; age above 18-75 years old; giving informed consent. Exclusion criteria: diabetes (assessed by measuring 126 <FBS); renal failure (with BUN, Cr); liver failure (evaluation of liver enzymes ALT, AST and bilirubin); drugs inhibit the immune system; taking pentoxifylline; taking cilostazol; an underlying infectious or inflammatory diseases (based on history and physical examination); having a history of sensitivity to curcumin (turmeric); high CRP (CRP) and Schiff Lvkvstvz the right (at least two positive CRP test qualitative biochemistry and CBC); taking glucosamine (due to inhibitory effects on the inflammatory NF?B); Egypt barberry extract, berberine (due to inhibitory effects on the inflammatory NF?B) and having a history of abuse syndromes induced absorption (based on history).

排除标准

  • 未提供

研究者

发起方
Mashhad University of Medical Sciences,vice chancellor for research

相似试验

Turmeric extract for the prevention of MI | 临床试验